Previous 10 | Next 10 |
Allscripts Healthcare Solutions (NASDAQ: MDRX ) initiated with Outperform rating and $8 (21% upside) price target at RBC. More news on: Allscripts Healthcare Solutions, Inc., Aprea Therapeutics, Inc., Avita Medical Limited, Healthcare stocks news, Stocks on the move, , Read more ...
In the age of COVID-19, social distancing measures have become the norm rather than the exception. As a result, many businesses are now struggling to stay afloat, and unemployment has soared. Fortunately, the U.S. government decided to step in, and on March 27, President Trump signed the Coronav...
The coronavirus disease 2019 (COVID-19) has completely changed how we as a society operate. Ideas that seemed almost unthinkable as recently as six weeks ago, such as the shutdown of nonessential businesses across the country to lessen the transmission of COVID-19, are now a reality. And the phy...
I suspect that most investors realize that the coronavirus-fueled stock market correction presents a great opportunity to buy stocks. Many don't have as much cash as they'd like to invest, though. And it can be overwhelming to try to pick the best stocks to buy with a limited amount of funds. T...
For the past eight weeks, we've witnessed record-breaking volatility in the stock market as a result of the coronavirus disease 2019 (COVID-19). The mitigation measures currently put in place to curb the transmission of COVID-19 have shut down most nonessential business activity and wound up pus...
Introduction You are a value investor. Over the years, you’ve spent countless hours trawling through oceans of stocks. However, being a value investor, and despite the constant searching, you cannot normally find stocks to fit your value-growth criteria. You know that companies wi...
Allogene Therapeutics (NASDAQ: ALLO ) initiated with Buy rating and $29 (28% upside) price target at SunTrust. More news on: Allogene Therapeutics, Inc., BridgeBio Pharma, Inc., Cerner Corporation, Healthcare stocks news, Stocks on the move, , Read more ...
MOUNTAIN VIEW, Calif., April 09, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that it has partnered with Prognos Health, an AI-driven pla...
What we're witnessing with regard to the spread of the coronavirus disease 2019 (COVID-19) is both unprecedented and tragic. Through Saturday, April 4, approximately 1.2 million cases of the coronavirus had been confirmed worldwide, with close to 65,000 people having been killed by this respirat...
Livongo Health (NASDAQ: LVGO ) expects preliminary Q1 revenue in the range of $65.5M to $66.5M, versus prior guidance of $60M to $62M. More news on: Livongo Health, Inc., Healthcare stocks news, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Would Teladoc (NYSE: TDOC) make a good fit for Berkshire (NYSE: BRK.A) (NYSE: BRK.B) ? In this clip from "The Rank" on Motley Fool Live , recorded on April 25 , Motley Fool contributor Zane Fracek makes the case for why he'd like to see Berkshire expand into heal...
Should You Buy These Health Care Stocks After Its Recent Dips? In the stock market today, investors appear to be cautious toward health care stocks as the COVID-19 vaccine roll-out gathers steam. While the pandemic has without a doubt place an enormous strain on the global healt...
Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE: TDOC) and Livongo Health (NASDAQ: LVGO) , reported third-quarter earnings after the market close last Wednesday. While each company delivered more than 100% top-line growth, both stocks sold off on...